Abbreviations used
AD-Atopic dermatitis aOR-Adjusted odds ratio BSA-Body surface area EASI-Eczema Area and Severity Index IQR-Interquartile range LCA-Latent class analysis NRS-numeric rating scale POEM-Patient-Oriented Eczema Measure SCORAD-SCORing Atopic Dermatitis epidemiological research has focused on childhood AD, but few have studied AD in adults. 1 Recent studies suggest that AD may be more common in adults than previously recognized, with 1-year US prevalence ranging from 3% to 10%. 2, 3 The higher than expected prevalence of AD may be attributed to high rates of persistent childhood disease and/or adult-onset disease. One longitudinal study found that 80% of children have persistence of AD symptoms into adulthood, with only 50% achieving a period of disease clearance by the age of 20 years. 4 However, a recent meta-analysis of 44 studies suggested that 50% and 80% of children with AD achieved a period of observed clear skin by 3 and 8 years of follow-up, respectively. 5 Thus, persistence of childhood AD is likely not the only factor contributing to adult AD. Over the past decade, several studies have reported substantial proportions of adults with AD having disease onset in adulthood (!18 years of age), that is, adult-onset AD. [6] [7] [8] [9] [10] [11] [12] We hypothesized that adults with AD have high rates of adult-onset disease.
Previous studies found that foreign-born American children had significantly lower rates of AD than those born in the United States; however, odds of AD in these children increased after having resided in the United States for more than 10 years. 13 Similarly, foreign-born American adults had significantly lower rates of asthma than those born in the United States; the odds of asthma in these adults also increased after having resided in the United States for more than 10 years. 14 These results suggest that foreign-born Americans may have later onset of AD and atopic disease. We hypothesized that adults born outside the United States have higher rates of adult-onset AD.
Still, little is known about the phenotypical differences between childhood AD and adult-onset AD. Recent studies showed an important role of barrier disruption in childhood AD and the atopic march in the development of atopic disease. 15 We hypothesized that adults with adult-onset AD have lower rates of atopic disease than those with long-standing AD and associated barrier disruption since childhood. Moreover, we hypothesized that adult-onset AD may present with different clinical characteristics than childhood disease. The present study sought to determine the proportion of adult AD with adult-onset AD, risk factors, and phenotypical differences of adult-onset AD.
METHODS

Study design
We performed a prospective dermatology practice-based study to determine the predictors of adult-onset AD. Self-administered questionnaires were completed by adult (!18 years) patients of the eczema clinic before their encounter. Surveys included questions about sociodemographic characteristics, birthplace, and age of moving to the United States for foreign-born Americans. Patients were then evaluated with a medical history and skin examination by a dermatologist. Surveys were administered between January 2014 and June 2016. The study was approved by the institutional review boards of the Northwestern University and informed consent was waived.
Assessment of AD
AD was assessed using the Hanifin and Rajka major and minor criteria. 16 Specific elements presented in this analysis include the major criteria (pruritus, distribution of eczematous lesions, personal or family history of AD, asthma, or hay fever) and the minor criteria (xerosis, ichthyosis, palmar hyperlinearity, keratosis pilaris, age of AD onset, nipple dermatitis, cheilitis, Dennie-Morgan infraorbital folds, facial pallor/erythema, conjunctivitis and eyelid dermatitis, pityriasis alba, dermatitis of the anterior neck folds, history of cutaneous infections, clinical course worsened by environmental or emotional factors, pruritus when sweating). AD severity was assessed using the numeric rating scale (NRS) for itch and sleeplessness, body surface area (BSA) of involved skin, SCORing Atopic Dermatitis (SCORAD), Patient-Oriented Eczema Measure (POEM), and Eczema Area and Severity Index (EASI).
Data processing and statistical methods
All data analyses and statistical processes were performed using SAS version 9.4 (SAS Institute, Cary, NC). Chi-square and Fisher exact tests were used to compare the age of AD onset (<18 years vs !18 years) with birthplace in the United States (binary); continent of birth (North America, Canada, South America, Europe, Asia, or Africa); whether AD preceded migration; personal history of asthma, hay fever, food and medication allergy (binary); family history of AD, asthma, hay fever, food and medication allergy (binary); and distribution of eczematous lesions and other signs and symptoms of AD (all binary). Median (interquartile range [IQR]) was determined for the number of combined signs and symptoms, EASI, SCORAD, BSA, NRS-itch, and NRS-sleep. Mann-Whitney U tests were used to compare these outcomes between adult-and childhood-onset groups. A 2-sided P value of .01 or less was taken to indicate statistical significance for all hypothesis tests.
Latent class analysis (LCA) was used to examine phenotypical patterns of binary variables of 19 signs and symptoms of AD. LCA uses observed categorical or binary data, termed latent classes, to identify patterns. Subjects with similar response patterns are categorized into specific classes. Conditional probabilities were estimated using maximum likelihood to characterize the latent classes by indicating the chance that a member would give a certain response (yes or no) for the specific item. Conditional probability plots are presented, where probabilities closer to 0 or 1 indicate lower or higher chances, respectively. LCA regression models examine the differential effects of individual variables across unobserved classes. The ideal number of latent classes and best-fitting models were selected by minimizing the Bayesian information criterion, consistent Akaike information criterion statistics, and interpretability. Multivariate logistic regression was then performed to determine the association between adult-onset AD and membership in the latent classes. Sex, race/ethnicity, BSA, and EASI were included as covariates to address potential confounding. Adjusted odds ratios (aORs) and 95% CIs were estimated.
Sample size calculation
A priori sample size calculations were performed on the basis of 2 coprimary analyses: the association between adult-onset AD and (1) foreign birthplace and (2) personal history of asthma or hay fever. For the association with foreign birthplace, the referent and test groups were predicted to be 13% and 26%, respectively, on the basis of the proportion of foreign-born adults in the US population 17 and an expected doubling of the proportion in adult-onset AD. For the association with personal history of asthma, the referent and test groups were predicted to be 50% and 25%, respectively, on the basis of previously observed prevalences in adults with AD 18 and an expected halving of that proportion in adult-onset AD. A total of 308 and 123 adults were needed on the basis of the chi-square test, assuming 90% power with the use of 2-sided tests and an alpha level of 0.01 for each outcome. 19 
RESULTS
Patient characteristics
Overall, 356 adults (aged 18-93 years) were included in the study, including 230 women (64.6%) and 228 whites (64.0%). The mean age at enrollment was 42.8 AE 16.7 years and the age of self-reported AD onset was 30.5 AE 31.7 years. Two hundred seven (58.1%) reported onset of AD during childhood and adolescence, with 88 (24.7%) before the age of 5 years and 87 (24.4%) after the age of 50 years ( Figure 1 ).
Among patients with adult-onset AD, skin biopsies were performed in 66 patients (44.3%); 65 patients showed a pattern of spongiotic dermatitis with eosinophils and none were consistent with cutaneous T-cell lymphoma. Patch testing was performed in 82 patients (55.0%); 56 patients were negative and 11 showed at least 1 irrelevant positive reaction. Fifteen patients showed at least 1 relevant positive reaction. However, strict avoidance of the observed allergens resulted only in partial mitigation of their underlying skin disease, with all patients having ongoing chronic AD. Skin prick testing results were available for 38 and 14 patients with childhood-and adultonset AD, respectively, with high rates of at least 1 positive allergen (single positive to aeroallergen: 7 [ excluded from the study because they did not meet the Hanifin and Rajka criteria for AD (63.3%), were found to have an alternative diagnosis on skin biopsy (6.1%), or were found to have allergic contact dermatitis that resolved with allergen avoidance (30.6%).
Patients with adult-onset AD were significantly more likely to be born outside the United States compared with those with childhood-onset AD (22.5% vs 11.5%; c 2 , P ¼ .008) (Table I) .
Among foreign-born adults with childhood-onset AD, 2 (14.3%) developed AD after migration to the United States, whereas among adults with adult-onset AD, 27 (75.0%) developed AD after migration (P ¼ .0003). However, adult-onset AD was not associated with sex, race/ethnicity, current smoking status, or alcohol consumption (P ! .11). 
History of atopic disease
Adult-onset AD compared with childhood-onset AD was associated with a significantly decreased personal history of asthma (17.8% vs 51.7%; P < .0001), hay fever (37.7% vs 58.7%; P ¼ .0001), and food allergy (15.4% vs 43.9%; P < .0001), but not medication allergy (30.5% vs 32.5%; P ¼ .70) (Table II) . Moreover, adult-onset AD compared with childhood-onset AD was associated with a significantly decreased family history of AD (35.5% vs 60.6%; P < .0001), asthma (20.0% vs 43.9%; P < .0001), and food allergy (10.4% vs 25.0%; P ¼ .0009), but not hay fever (23.9% vs 36.2%; P ¼ .017) or medication allergy (9.0% vs 14.8%; P ¼ .12).
Signs and symptoms of AD
Adult-onset AD compared with childhood-onset AD was associated with significantly higher rates of nummular eczema lesions, but lower rates of 11 of 18 signs and symptoms of AD, including dermatitis affecting anterior neck fold, scalp, face, eyelids and conjunctivitis, Dennie-Morgan folds, hands or feet, nipples, cheilitis, pityriasis alba, keratosis pilaris/palmar hyperlinearity/ichthyosis, clinical course worsened by emotional or environmental factors, pruritus when sweating, and tendency toward cutaneous infections (Table II) . However, there were no significant differences of dermatitis affecting the flexural areas, xerosis, white dermatographism, follicular eczema, anterior subcapsular cataracts, and keratoconus. Furthermore, patients with adult-versus childhood-onset AD had a significantly lower number of combined AD signs and symptoms (median [IQR], 6 [2-8] vs 10 [6] [7] [8] [9] [10] [11] [12] [13] ; P < .0001) (Figure 2, A) .
AD severity
There were no significant differences of disease severity between adult-onset and childhood-onset AD as judged by (Figure 2 (Figure 2, F) , or POEM (median [IQR], 10 [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] vs 12 [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] ; P ¼ .43) (Figure 2, G) .
LCA of the adult-onset AD phenotype
LCA was used to identify phenotypical patterns associated with adult-onset AD. The best-fitting model had 3 classes on the basis of the minimal Bayesian information criterion, consistent Akaike information criterion, and interpretability. Conditional probabilities of having different physical signs and symptoms in each class are plotted in Figure 3 . Class 1 had high probabilities of flexural dermatitis and xerosis with intermediate to high probabilities of head, neck, and hand dermatitis. Class 2 had high probabilities of flexural dermatitis and xerosis, but low probabilities of head, neck, and hand dermatitis. Class 3 had a lower probability of flexural dermatitis, but the highest probabilities of virtually all other signs and symptoms. Adult-onset AD was significantly associated with class 1 (multivariate logistic regression; aOR, 5.54; 95% CI, 1.59-19.28) and class 3 (aOR, 14.03; 95% CI, 2.33-84.50). That is, adult-onset AD was more likely to present with a phenotype consisting of lower probability of flexural dermatitis (class 3) and/or higher probability of hand and/or head and neck dermatitis (classes 1 and 3) .
DISCUSSION
The present study demonstrated that adult-onset AD is associated with a distinct phenotype compared with childhoodonset AD, including less frequent personal and/or family history of atopic disease, fewer signs and symptoms of AD, a higher probability of lesions affecting the head/neck and hands, and a lower probability of flexural lesions. These findings are consistent with previous studies showing more nummular eczema lesions, less flexural involvement, and lesional predilection for the hands and face in adult-onset AD. 7,20 However, we found significantly lower rates of scalp and posterior auricular lesions and no differences for rates of follicular eczema. This is in contrast with a previous study that found higher rates of both scalp and posterior auricular involvement and follicular eczema. 7 Despite the observed phenotypical differences, we found no significant differences in AD severity, patient-reported intensity of itch or sleeplessness, disease activity (POEM), or pruritus when sweating. Thus, adult-and childhood-onset AD appear to have similar severity, symptomatology, and quality-of-life impairment, despite the observed phenotypical differences. It is important for clinicians to account for the different phenotypes of adult-onset AD when evaluating and managing adult patients with dermatitis.
There are several practical points from this study for the management of adult AD. First and foremost, clinicians must recognize that the presentation of adult AD is more heterogeneous and may have different phenotypes. It is of course important to rule out other entities in the differential diagnosis, for example, allergic contact dermatitis and cutaneous T-cell lymphoma. However, the clinician can comfortably make the diagnosis of AD if the clinical presentation is consistent with AD and the appropriate workup for other etiologies is negative. Second, the lesional predilection for the head/neck and hands may require site-specific targeted treatment with either lowpotency topical corticosteroids or nonsteroidal topical agents for the head/neck area and superpotent topical corticosteroids for the hands. Third, the similar rates of xerosis between childhoodand adult-onset AD suggest that moisturizers and other barrier repair therapies are warranted in both patient subsets. Fourth, given the low rates of history and manifestations of atopic disease, skin prick and RAST testing may not be warranted in the routine workup of most patients with adult-onset AD, whereas these may be useful in a subset of adults with childhood-onset AD and those with comorbid asthma and rhinoconjunctivitis. However, it may be that uncontrolled AD in adulthood may predispose to eventual higher rates of adult-onset atopic disease. This is analogous to the "atopic march" observed in a subset of childhood AD. 21 Thus, improved long-term control of the skin disease may offer an opportunity to mitigate or prevent adultonset atopic disease. Finally, it is unknown whether the distinct phenotypes observed in this study are associated with different prognoses or treatment responses. A recent metaanalysis found that children with already persistent, later-onset, and/or more severe AD had increased persistence. 22 Adultonset AD may similarly be associated with increased persistence and thus warrant long-term treatment regimens. Yet, it is unknown whether specific clinical interventions may prevent childhood AD from becoming adult AD. Future long-term studies are needed to elucidate these points.
The results of this study confirm our hypothesis that adults with AD have high rates of adult-onset disease. Adult-onset AD may be more common than commonly recognized and may affect almost half of all adult cases. A US population-based telephone survey of 60,000 households similarly found that 54% of respondents with self-reported AD reported their disease onset in adulthood. 6 Studies from Turkey, Singapore, Australia, Italy, Nigeria, and China also reported that substantial proportions (range of 9%-88%) of patients with AD had onset after age 18 years. [7] [8] [9] [10] [11] [12] Of course, some of these patients may have in fact had childhood disease but were unaware of or have forgotten it. Regardless of whether such cases are adult onset per se or adult recurrence of AD, there appears to be a larger subset of patients with activation of their skin disease in adulthood than previously recognized.
The present study confirms our hypothesis that foreign-born patients were more likely to have adult-onset AD compared with those born in the United States. We previously demonstrated that foreign-born American children had significantly lower rates of AD and atopic disease than those born in the United States. 23 However, the odds of AD increased significantly in foreign-born children after residing in the United States for 10 or more years. 23 Together, it appears that foreign-born Americans are at risk for later-onset AD, particularly in adulthood.
We found no significant sex associations with adult-onset AD or with the associated phenotypes involving the hands and/or head/neck. In contrast, the US prevalence of adult AD was associated with female sex 3 and one study showing a male preponderance of adult-onset AD. 7 The complex relationship between sex, skin care practices, occupational exposures, and the pathogenesis of AD require further study. We observed high rates of cigarette smoking and alcohol consumption in this cohort overall, consistent with previous reports of increased smoking in children and adults and alcohol consumption in adults with AD. 24, 25 However, there were no associations between adultonset AD per se and current smoking status or alcohol consumption. This is in contrast with a case-control study of 225 Taiwanese adults that found that early and/or current exposure to cigarette smoking was associated with adult-onset disease. 26 However, that study compared adult-onset AD to non-AD controls and those findings may have been attributable to AD, in general, and not adult-onset AD, in particular.
The mechanisms of adult-onset AD remain unclear. Perhaps the biggest question is whether such cases are truly adult onset or adult recurrence of AD. It is possible that adults presenting with new-onset disease including the full spectrum of AD signs and symptoms and comorbid allergic disease are actually cases of adult recurrent disease. However, adults presenting with prominent head/neck and hand/foot involvement and lower rates of allergic disease may truly be cases of adult-onset AD. Alternatively, it is possible that even adult recurrent disease is more likely to present with prominent head/neck and hand/foot involvement. Either way, it is mysterious that patients should have decades or a lifetime of clear skin and subsequently develop full-blown AD. Presumably, any genetic predisposition toward AD would have been programmed from birth. A study of 241 patients with AD found that the 4 most common filaggrin lossof-function mutations were associated only with early childhoodonset AD ( 2 years or 2-8 years), but not late-childhood (8-17 years) or adult-onset (!18 years) disease. 27 This suggests that there are different genetic and/or environmental determinants of adult-onset AD, which warrant further study. Future studies are warranted that compare the genetics and transcriptome of childhood-versus adult-onset AD.
This study has several strengths. It is a prospective study that makes a standardized assessment of AD signs, as well as pruritus, sleeplessness, disease activity, and severity, using multiple validated instruments. In addition, alternative diagnoses in the differential diagnosis were ruled out using skin biopsy and/or patch testing when indicated. LCA was used to identify the dominant phenotypes of adult AD and was able to detect 3 unobservable subgroups of patients, including those with lesional predilection for the hands/feet and/or head/neck. However, the study has limitations. In particular, the study was performed in an academic dermatologic setting and may not be generalizable to milder cases of AD or the entire US population.
CONCLUSIONS
Adults with AD have high rates of self-reported adult-onset AD, lower prevalence of personal or family history of atopic disease, distinct phenotypes with less flexural lesions and more involvement of the hands and/or head/neck, and higher rates of nummular lesions. Future longitudinal studies are underway to determine whether these phenotypes are associated with different prognoses or treatment responses.
